Clinical Trials Directory

Trials / Completed

CompletedNCT02383407

Low Frequency Electrical Stimulation of the Fornix in Intractable Mesial Temporal Lobe Epilepsy (MTLE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
6 (actual)
Sponsor
George Washington University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The primary aim of the current proposal is to evaluate safety and tolerability, in terms of neuropsychological effects of low frequency electrical stimulation of the fornix (LFSF) in participants with medically-intractable Mesial Temporal Lobe Epilepsy. Secondary aims include evaluation of psychiatric changes, seizure frequency, and quality of life during LFSF.

Detailed description

Low frequency stimulation is an attractive, uninvestigated method for treatment of intractable epilepsy. Preliminary animal and human data suggest safety and remarkable efficacy of Low frequency stimulation (LFS) in epilepsy. In addition, the duty cycle of LFS is very low, implying less electric current injection, with less charge density on the target tissue and electrodes, and longer battery life. The current project is a classic translational, single-blinded, randomized research project, demonstrating a clear path from the laboratory to bedside. If successful, this new therapy will be of great value to patients with medically and surgically intractable Mesial Temporal Lobe Epilepsy (MTLE). The study is expected to last approximately 5 years, from enrollment of the first patient to completion of the final subject, taking into consideration attrition and otherwise-eligible subjects who will not elect to participate. Once the study is completed, and enrolled participants have completed all required elements of the protocol, a final report will be submitted to the FDA. Participants may also discontinue their participation in the study, if they wish, at any time.

Conditions

Interventions

TypeNameDescription
DEVICEMedtronic Deep Brain Stimulation

Timeline

Start date
2013-12-01
Primary completion
2018-01-01
Completion
2019-01-01
First posted
2015-03-09
Last updated
2023-06-26
Results posted
2023-06-26

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02383407. Inclusion in this directory is not an endorsement.